Literature DB >> 18973635

Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema.

Marcin A Sosnowski1.   

Abstract

Opiates have traditionally been used as one of the main treatments of acute heart failure and are still recognized as such. Most current textbooks and official guidelines advise the use of morphine as one of the first-line treatments for patients in acute cardiogenic pulmonary oedema and a majority of physicians accept it to be the case. The author performed an extensive literature search in order to validate the evidence for the use of opiates in this condition. A total of seven papers, six in English and one in Polish, were found that directly investigated or reported the clinically important outcomes of treatment of acute pulmonary oedema. Only five of these dealt specifically with the effects of administration of opiates in acute cardiogenic pulmonary oedema. None of the above publications suggested a clinically significant improvement in outcomes of patients treated with morphine, although early research did suggest reduced anxiety, blood pressure and pulse rate as well as a reduction in arterial oxygen contents. The more recent studies suggest a strong association between increased mortality and morbidity (e.g. intensive care unit admissions or intubation rates), although causality is difficult to establish because of research methodologies. The current evidence does not support the routine use of opiates in the treatment of acute pulmonary oedema.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18973635     DOI: 10.1111/j.1742-6723.2008.01113.x

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  8 in total

Review 1.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

2.  Morphine Use in the Treatment of Acute Cardiogenic Pulmonary Edema and Its Effects on Patient Outcome: A Systematic Review.

Authors:  Víctor Gil; Alberto Domínguez-Rodríguez; Josep Masip; W Frank Peacock; Òscar Miró
Journal:  Curr Heart Fail Rep       Date:  2019-08

3.  A critical appraisal of the morphine in the acute pulmonary edema: real or real uncertain?

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Harmful impact of morphine use in acute heart failure.

Authors:  Kotaro Naito; Takashi Kohno; Keiichi Fukuda
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Morphine in acute heart failure: good in relieving symptoms, bad in improving outcomes.

Authors:  Òscar Miró; Víctor Gil; W Frank Peacock
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 6.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

Review 7.  Sympathetic crashing acute pulmonary edema.

Authors:  Naman Agrawal; Akshay Kumar; Praveen Aggarwal; Nayer Jamshed
Journal:  Indian J Crit Care Med       Date:  2016-12

8.  Morphine blocks the Mesobuthus tamulus venom-induced augmentation of phenyldiguanide reflex and pulmonary edema in anesthetized rats.

Authors:  Aparna Akella; Anil K Tiwari; Om P Rai; Shripad B Deshpande
Journal:  Indian J Pharmacol       Date:  2016 Jan-Feb       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.